Johnson & Johnson to buy heart failure implant company V-Wave for up to $1.7B

Fierce Biotech August 20, 2024
Heather Landi

Johnson & Johnson said Tuesday it will buy heart failure implant company V-Wave in a deal worth a potential $1.7 billion.

J&J entered into a definitive agreement to acquire the privately held company for an upfront payment of $600 million, subject to customary adjustments, with the potential for additional regulatory and commercial milestone payments up to approximately $1.1 billion. V-Wave will join J&J as part of its medtech division, the company said.

The planned acquisition of V-Wave will extend J&J MedTech’s position as an “innovation leader in addressing cardiovascular disease,” the company said in a press release. It will further “accelerate its shift into high-growth and high-opportunity markets and will deepen its relationships with structural interventional cardiologists and heart failure...

Today's Sponsors

Today's Sponsor